Nearly 44 million people have Alzheimer's or related dementia worldwide, according to the Alzheimer's Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia.First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to other symptoms, and the quality of life for those with Alzheimer's disease. In addition, the book discusses recent studies on memory dysfunction in advanced-stage Alzheimer's disease, in comparison to early-stage, including a chapter on the underlying factors in the transition from mild cognitive impairment to Alzheimer's diagnosis. Following this section, the book presents recent studies on the role of different cortical and subcortical structures in the development of various symptoms in Alzheimer's disease, as well as different neural biomarkers underlying the development and treatment of the disease. In the last section of the book, therapeutic aspects of Alzheimer's disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, are reviewed. The book aids readers in understanding the advances in research and care, making it a prime tool for all clinicians, psychologists, researchers, neurologists, and caregivers of dementia patients. - Reviews recent developments of cognitive and clinical studies - Covers factors underlying the transition from mild cognitive impairment to Alzheimer's disease - Discusses different neural biomarkers underlying the development and treatment of Alzheimer's disease - Provides a comparison of the effectiveness of various types of treatments

Offering a comprehensive overview of dementia for psychiatrists and other health care practitioners, the authors review pharmacologic, behavioral, and environmental treatments, and present information on nearly every subject related to dementing conditions or illnesses.

Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Detailed case studies facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.

The reference is a broad-ranging review of Alzheimer's disease and other dementias from both basic and clinical neuroscience perspectives; it provides scientists and medical professionals with an extensive introduction and an up-to-date review of cutting-edge scientific advances. Brings the reader up-to-date with cutting-edge developments in this exciting and fast-paced field Summarizes the most recent developments in the fields of Alzheimer's disease and dementia Brings together articles from a prominent and international group of contributors Encompasses a unique range of topics, combining basic molecular perspectives and cognitive neurosciences

In Clinical Manual of Alzheimer Disease and Other Dementias, practicing psychiatrists and neurologists provide essential input into neuropsychiatric assessment and the diagnosis and treatment of a wide range of neuropsychiatric conditions, including Alzheimer disease and traumatic brain injury. The manual provides invaluable information on both evaluation/diagnosis and treatment. Case studies offer real-life clinical experiences by some of the country's leading experts in the field. Clinical Manual of Alzheimer Disease and Other Dementias Includes DSM-IV-TR cognitive disorders and addresses other cognitive syndromes and psychiatric symptoms that may confound diagnosis. Provides clinical insights into the diagnostic signs and symptoms of dementing illnesses, including Alzheimer disease, frontotemporal dementias, delirium, amnesia, and other cognitive disorders. Reviews the psychiatric syndromes that are related to dementing illnesses and deals with their treatment. Discusses the detection and management of depression in the evaluation of a person with a cognitive complaint or symptoms. Emphasizes the behavioral disorders that accompany dementing illness and presents an approach to their pharmacological and nonpharmacological management. Delineates clinical workup for medical conditions that may underly cognitive or other psychiatric symptoms. Provides an overview of clinical tools and techniques for diagnosing cognitive dysfunction, including history taking, mental status evaluation, physical and neurological examination, and neuropsychological testing. Presents an illustrated review of the most current techniques of neuroimaging in differential diagnosis. Includes key clinical points in every chapter summarizing important concepts. In addition to topics covered in the textbook, the manual includes a chapter on community resources to enable clinicians to better support patients and families through local and national organizations and agencies. This text is a must-have reference for clinical psychiatrists, resident fellows, residents in training, medical students in psychiatry rotations, clinical psychologists, and psychiatric nurses.

This book provides a practically focused resource on the methodologies available for diagnosing and treating Alzheimer’s disease. The number of individuals affected by the disease continues to grow and as such there is an ever-increasing need for clear easy-to-digest guidance on how to appropriately diagnose and treat these patients. Within this work, chapters provide concise informative details of what this form of dementia is, how it can be diagnosed, managed and prevented making it ideal for those with limited experience in dealing with these patients. Information is provided on how to use a variety of the latest relevant techniques including mental state examinations, functional assessments, special investigations and the available drug treatments. Alzheimer’s Disease: Diagnosis & Treatment Guide is a concise clinical guide detailing how to diagnose and treat these patients. It’s easy-to-follow ideal for use by front-line physicians and trainees, who have no previous experience of diagnosing and treating this disease. The assessment component of the book is based on the WHO Mental Health Gap Action Plan (mhGAP) Dementia Intervention Guide for non-specialized settings.

Alzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer's disease (AD) in human populations, providing the reader with knowledge on how we define the disease and what its risk and protective factors are in the context of a life-course approach. At the conclusion of the book, the reader will understand why Alzheimer's disease likely begins at conception, then progresses through early-life and adult risk factors that ultimately impact the balance between pathologic insults in the brain and the ability of the brain to modify disease symptoms. In contrast to edited volumes that may have little cohesion, this book focuses on an integrated life-course approach to the epidemiology of dementia, in particular, Alzheimer's disease. - Reviews the current science surrounding Alzheimer's disease - Provides a primer of foundational knowledge on the disease's epidemiology and biostatistics - Utilizes a life-course approach, providing a novel and integrated view of the evolution of this illness from genes to brain reserve - Uses the 'threshold model'—a theory first described by Dr. Mortimer and widely accepted today—which incorporates the idea of risk factors for the pathology and expression of the disease - Proposes that improving brain health through modifiable behaviors can delay disease onset until a later age - Examines the future of prevention of Alzheimer's disease, a subject of great current interest